272 related articles for article (PubMed ID: 20379736)
1. Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab.
He YG; Wang H; Zhao B; Lee J; Bahl D; McCluskey J
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1519-21. PubMed ID: 20379736
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children.
Kaul S; Uparkar M; Mody K; Walinjkar J; Kothari M; Natarajan S
Indian J Ophthalmol; 2010; 58(1):76-8. PubMed ID: 20029154
[TBL] [Abstract][Full Text] [Related]
4. Resolution of macular edema in Coats' disease with intravitreal bevacizumab.
Entezari M; Ramezani A; Safavizadeh L; Bassirnia N
Indian J Ophthalmol; 2010; 58(1):80-2. PubMed ID: 20029156
[TBL] [Abstract][Full Text] [Related]
5. Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection.
Jun JH; Kim YC; Kim KS
Korean J Ophthalmol; 2008 Sep; 22(3):190-3. PubMed ID: 18784449
[TBL] [Abstract][Full Text] [Related]
6. Management of Coats disease with bevacizumab in 2 patients.
Venkatesh P; Mandal S; Garg S
Can J Ophthalmol; 2008 Apr; 43(2):245-6. PubMed ID: 18347637
[No Abstract] [Full Text] [Related]
7. Vascular endothelial growth factor in Coats' disease.
Zhao Q; Peng XY; Chen FH; Zhang YP; Wang L; You QS; Jonas JB
Acta Ophthalmol; 2014 May; 92(3):e225-8. PubMed ID: 23764089
[TBL] [Abstract][Full Text] [Related]
8. The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.
Zheng XX; Jiang YR
Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):35-42. PubMed ID: 23873253
[TBL] [Abstract][Full Text] [Related]
9. Coats' disease: treatment with intravitreal bevacizumab and laser photocoagulation.
Stergiou PK; Symeonidis C; Dimitrakos SA
Acta Ophthalmol; 2009 Sep; 87(6):687-8. PubMed ID: 18976310
[No Abstract] [Full Text] [Related]
10. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease.
Raoof N; Quhill F
Middle East Afr J Ophthalmol; 2013; 20(3):256-8. PubMed ID: 24014992
[TBL] [Abstract][Full Text] [Related]
11. Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium.
Sun Y; Jain A; Moshfeghi DM
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1387-8. PubMed ID: 17342503
[TBL] [Abstract][Full Text] [Related]
12. Combined intravitreal bevacizumab and argon laser treatment for Coats' disease.
Cackett P; Wong D; Cheung CM
Acta Ophthalmol; 2010 Mar; 88(2):e48-9. PubMed ID: 19500078
[No Abstract] [Full Text] [Related]
13. Intravitreal bevacizumab therapy for idiopathic macular telangiectasia.
Matsumoto Y; Yuzawa M
Jpn J Ophthalmol; 2010 Jul; 54(4):320-4. PubMed ID: 20700800
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment of pediatric coats' disease: a bicenter study in Taiwan.
Lin CJ; Chen SN; Hwang JF; Yang CM
J Pediatr Ophthalmol Strabismus; 2013; 50(6):356-62. PubMed ID: 24669373
[TBL] [Abstract][Full Text] [Related]
15. The effect of intravitreal bevacizumab in the treatment of Coats disease in children.
Lin CJ; Hwang JF; Chen YT; Chen SN
Retina; 2010 Apr; 30(4):617-22. PubMed ID: 19996822
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
Sawada O; Kawamura H; Kakinoki M; Sawada T; Ohji M
Arch Ophthalmol; 2007 Oct; 125(10):1363-6. PubMed ID: 17923544
[TBL] [Abstract][Full Text] [Related]
17. Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.
Sohn EH; He S; Kim LA; Salehi-Had H; Javaheri M; Spee C; Dustin L; Hinton DR; Eliott D
Arch Ophthalmol; 2012 Sep; 130(9):1127-34. PubMed ID: 22965588
[TBL] [Abstract][Full Text] [Related]
18. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
Bhat V; D'Souza P; Shah PK; Narendran V
Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
[TBL] [Abstract][Full Text] [Related]
19. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab.
Nonobe NI; Kachi S; Kondo M; Takai Y; Takemoto K; Nakayama A; Hayakawa M; Terasaki H
Retina; 2009 May; 29(5):579-85. PubMed ID: 19430279
[TBL] [Abstract][Full Text] [Related]
20. Increased nitric oxide and vascular endothelial growth factor levels in the aqueous humor of patients with coats' disease.
Zhang H; Liu ZL
J Ocul Pharmacol Ther; 2012 Aug; 28(4):397-401. PubMed ID: 22233441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
